findmyKOL

Simon Khagi, MD

Basic profile

Dartmouth–Hitchcock Medical Center

ORCIDNPI
RegionNewport Beach, CA · WestSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Simon Khagi is an Oncology physician affiliated with Dartmouth–Hitchcock Medical Center. OpenAlex indexes 78 publications with 1,904 citations (h-index 15).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
78publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,904citations

Total citations across indexed works.

15h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
19companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1 Hoag Dr Bldg 41
Newport Beach, CA 926634162

Telephone

949-764-4060

Provider last certified this registry record 27 Nov 2023.

View the NPPES registry record

Industry payments

19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    41.8%
    SSRI19.1%
    Fluoxetine Hcl100%
    Part D17 patients
    Other antiepileptics6.7%
    Levetiracetam100%
    Part D12 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    25%
    Serotonin-3 Receptor Antagonist11.9%
    Ondansetron Odt70%Ondansetron Hcl30%
    Part D19 patients
    Proton pump inhibitor4.1%
    Pantoprazole Sodium100%
    Part D11 patients

    + 3 more classes in this area

  • Cancer & immunology

    10.1%
    Kinase inhibitor8.1%
    Tagrisso100%
    Part D<11 patients
    Other antineoplastic agents1.9%
    Lumakras100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”